MORC3 and dermatomyositis: Twenty patients with a diagnosis of DM were selected, including anti-MDA5 (n = 7), anti-Mi-2 (n = 4), anti-SAE1 (n = 4), anti-NXP2 (n = 3), and anti-TIF-γ (n = 2).